Opal's Life Sciences, Pharmaceutical and Healthcare Events
Opal's education and networking conferences, events and summits
 
2nd Annual Drug Discovery: Easing The Bottleneck
2nd Annual Drug Discovery:
Easing The Bottleneck
 
October 17-18, 2011
Hilton Boston Logan Airport, Boston, MA
Add Drug Discovery: Easing the Bottleneck to your outlook calendar
 
Register Now for the Drug Discovery:
Easing the Bottleneck
 
VIEW CONFERENCE DETAILS
(Attendees current as of 10-13-11)
  2011 Attendees:
 

Senior Director of Discovery, Ablynx
CEO, ActoKine Therapeutics
Science and Publications Editor, Albert Einstein College of Medicine
Senior Director of Product Development, Alkermes
Doctor, ALS Society of Canada
Founder & CEO, American MedChem
Director. Amgen
Principal Scientist, Amgen
Business Development Manager, AstraZeneca
Director, Head of Neuroscience Preclinical Business Development, AstraZeneca
Informatics Scientist, AstraZeneca
Principal Scientist, AstraZeneca
Vice President, Business Development, Athena Diagnostics
President, AWIS
Manager, Baxter Healthcare Corporation
Global Drug Discovery Operations, Bayer Healthcare
Vice President of Business Development, Bayer Healthcare
Senior Principle Scientist, Boehringer Ingelheim Pharmaceuticals
Business Development Analyst, Boston University
Associate Professor, Boston University School of Medicine
Research Assistant Professor- Department of Pathology, Boston University School of Medicine
Licensing Associate, Brigham and Women's Hospital
Senior Scientist, Brigham and Women's Hospital
Manager, Bristol Myers Squibb
Clinical Pharmacology Lead, Bristol Myers Squibb
Vice President, Drug Discovery Cambria Biosciences Innovative Technology, Cambria BioSciences
Business Manager, Cancer Research Technologies
Managing Director, Cancer Research Technologies
Business Development Manager, Capsugel
Research Scientist, Cephalon
Senior Scientist, Cephalon
Chief Business Officer, Chattanooga Research Institute
Co-Founder, Chattanooga Research Institute
Co-Founder and CSO, Chattanooga Research Institute
Patient Coordinator, Children's Hospital of Boston
Licensing Manager, Technology and Innovation Development, Children's Hospital of Boston
Assistant Professor, Children's Hospital of Boston
Business Development Manager, Children's Hospital of Boston
Technology Development Manager, Children's Hospital of Boston
CEO, ChronoDose
CFO, ChronoDose
Department Chair, Industrial Pharmacy, College of Pharmacy- University of Manila
Government Academe, College of Pharmacy- University of Manila
Instructor, College of Pharmacy- University of Manila
Founder and CEO, Concept of Cures
Business Development Manager, Corning
Business Director- Advanced Life Sciences, Corning
Director, Science and Technology Licensing, Cubist Pharmaceuticals
Research Scientist, Cubist Pharmaceuticals
Senior Scientist, Cubist Pharmaceuticals
General Manager, CyBio
Licensing Associate, Dana Farber Cancer Institute
Manager of Lead Discovery, Dart Neurosciences
Chief Executive Officer, Chief Scientific Officer, Director & Founder, Discovery BioMed
Head of Business Development, Discovery Biomed
Associate Director, Duke University, Office of Licensing and Ventures
Executive Director, Duke University, Office of Licensing and Ventures
Marketing Director, Edwards Angell Palmer & Dodge
Partner, Edwards Angell Palmer & Dodge
Partner, Edwards Angell Palmer & Dodge
Senior Counsel, Eisai Pharmaceuticals
CSO, ELARA Pharmaceuticals
Consultant, Eli Lilly & Company
Neuroscience Primary Care Representative, Eli Lilly & Company
Senior Research Advisor, Group Leader, Eli Lilly  & Company
Research Associate, EMD Serono
Research Associate, EMD Serono
Scientist I, EMD Serono
Scientist, EMD Serono
Senior Scientist, EMD Serono
MBA Candidate, Emory University
Senior Licensing Associate, Emory University
CEO, Enumeral Biosciences
Director of Business Development, Enumeral Biosciences
CEO, Excelimmune
Senior Director, Extex Corporation
Investigator, FDA
Senior Regulatory Operations, FDA
Dean of Pharmecutical Science, Florida A & M
Business Development Associate, Freedom Meditech
Principal Research Associate, Genzyme Corporation
Associate Professor, Georgetown University
Director Center for Operational Research in Medicine, Georgia Institute of Technology
Director of Business Development, GL Chemtec International
Associate Director of Business Development, Harvard Medical School
Business Development Associate, Harvard Medical School
Executive Director, Harvard Medical School
Professor, Harvard Medical School
Program Director, Harvard Medical School
Senior Cancer Biology Assay Developer, Harvard Medical School
Associate Director, Bioinformatics Core, Harvard School of Public Health, Research Science Department of Biostatistics
Research Fellow, Harvard School of Public Health, Research Science Department of Biostatistics
Director of Business Development, Harvard University
Vice President, Hawaii Biotech
CEO, HealthGlobe International
COO, HealthGlobe International
Case Manager, Hogar Nuevo Pacto
Chief Medical Officer, iCanDxRx
Director, Idenix Pharmaceuticals
Scientist, Immunomedica
Associate Director, Ipsen
Director, Compound Discovery, Ipsen
Director, Molecular Endocrinology, Ipsen
Principal Scientist, Ipsen
Principal Scientist, Ipsen
Senior Scientist, Ipsen
Senior Director of Medical Sciences, Ipsen
CEO, IRND3 Institute for Rare and Neglected Disease Drug Discovery
Director, Lakenau Institute for Medical Research
Representative, Lumicell Diagnostics
Vice President, Research, Lundbeck
Post Doctoral Fellow, Massachusetts General Hospital
Student, Massachusetts Institute of Technology
Student, Massachusetts Institute of Technology
Student, Massachusetts Institute of Technology          
Business Strategy and Licensing Manager, MassBiologics
Founder and Executive Director, Mass Medical Angels
Scientist, MedImmune
Managing Partner, MediSynergics
Managing Partner, MediSynergics

 

Development Fellow, Merck
Director- ETS, In Vitro Cellular Pharmacology, Merck
Research Biochemist, Merck
In Vitro Pharmacology, Merck Research Labratories
CEO, Mercury Therapeutics
Senior Scientist, Momenta Pharmaceuticals
Deputy Director, National Institute of Diabetes, Digestive and Kidney Diseases
Technology Transfer Manager, National Institute of Health, Center for Translational Therapeutics
Head of High Throughput Screening and Drug Discovery Lab, Nemours Center for Childhood Cancer Research
Vice President of Research and Development, New York Stem Cell Foundation
Associate Director, New York University
Business Venture Analyst, New York University
Manager of New Venture Development, New York University
UNCF- Merck Postdoctoral Fellow, Northwestern University
Investigator, Novartis
Group Leader, Sample Management Group, Novartis
Scientist II, Sample Management Group, Novartis
Scientist I, Sample Management Group, Novartis
Scientist I, Sample Management Group, Novartis
Group Leader, Sample Management Group, Novartis
Market Research & Insights- Global Public Health and Market Access, Novartis
Principal Fellow, Pharmaceutical & Analytical Development, Novartis
CEO, Nuortho Surgical
CEO, Ocean Therapeutics
President, P.A.R. Pharmaceuticals
Associate Director, Process and Manufacturing, Paratek Pharmaceuticals
Principal Scientist, Paratek Pharmaceuticals
Scientist, Paratek Pharmaceuticals
Senior Scientist, Paratek Pharmaceuticals
Executive Director, Partners Healthcare
Radiochemist, Partners Healthcare
Business Strategy and Licensing Manager, Partners Healthcare/Massachusetts General Hospital
Chief Laboratory Director at Laboratory for Molecular Medicine, Partners Healthcare Center for Personalized Genetic Medicine
Assistant Laboratory Director, Partners HealthCare Center for Personalized Genetic
CEO/COO, Personalized Pharmaceutical
Engineer, Pfizer
Director of Orphan and Genetic Diseases, Pfizer
Head of Protein Chemistry Group, Pfizer
Legal Specialist, Pfizer
Regulatory Affairs Scientist, Pfizer
Research Scientist, Pfizer
Senior Director, Pfizer
Senior Director of Enterprise Architecture, Pfizer
Senior Principal Scientist, Pfizer
PhD Student, Dr. Celia Schiffer's Laboratory Biochemistry and Molecular, Pharmacology University of Massachusetts Medical School
Business Development, Proteologics
Scientist, Proteostasis Therapeutics
Technical Manager, Ricerca BioSciences
Director, Rutgers University
Graduate Student, Rutgers University
President, Samanen Consulting
Scientist, Sanford-Burnham Medical Research Institute
Senior Research Investigator, Sanofi Aventis
Student, Skidmore University
Student, Skidmore University
PhD Candidate, SUNY Albany
Business Development Manager, Synthonix
President, Synthonix
Assistant Director- The Stanley Center for Psychiatric Medicine, The Broad Institute
Director of Medicinal Chemistry, The Broad Institute
Manager of Screening Outreach, The Broad Institute
Research Scientist, The Broad Institute
Director, Technology Transfer and Commercialization, The Henry M. Jackson Foundation for the Advancement of Military Medicine
Assistant Director, Technology Transfer Office, The Jackson Laboratory
Senior Director, Technology Evaluation and Development, The Jackson Laboratory
President, ThinkBiotech
Drug Discovery, The School of Pharmacy, UCL
Project Manager, Tufts Center for Drug Development
Director, Teaching and Research Resources, Tufts Cummings School of Veterinary Medicine
Professor, Tufts Medical School
Licensing Associate, Tufts University
Associate Director, Tufts University
Research Associate, Tufts University
Faculty Manager, Tufts University Office of Technology Licensing
Graduate Student Researcher, Tufts University Office of Technology Licensing
Faculty Member, Tufts University: School of Medicine
Research Assistant, UMass Medical School
Senior Research Associate, UMass Medical School
Licensing Officer, UMass Medical School, Technology Transfer Office
Licensing Officer, UMass Medical School, Technology Transfer Office
Licensing Officer, UMass Medical School, Technology Transfer Office
Licensing Officer, UMass Medical School, Technology Transfer Office
Licensing Officer, UMass Medical School, Technology Transfer Office
Research Scientist, University of Cincinnati: Drug Discovery Center
Director, University of Colorado- Technology Transfer Office
Research, University of Connecticut
Associate Director, University of Massachusetts
Assistant Vice Chancellor Research Development, University of Massachusetts Dartmouth
Research Assistant Professor, University of Massachusetts Medical School
Professor and Chair, University of Medicine and Dentistry of New Jersey
Director, Patents & Licensing, University of Medicine & Dentistry of New Jersey
Adjunct Assistant Professor of Medicine, Drug Development Analyst, Department of Medicine/Geriatrics, University of Pennsylvania School of Medicine
Professor, University of the Philippines Manila
Research Project Manager, University of Pittsburgh
Assistant Professor, Center for Molecular Biophysics, University of Tennessee/Oak Ridge National Laboratories
Interim Director, University of Vermont
Professor of Biochemistry, University of Vermont
Senior Advisor to the President, University of Vermont
Operations Research Scientist, Vertex Pharmaceuticals
Research Fellow, Vertex Pharmaceuticals
Scientist, Vertex Pharmaceuticals
Scientist, Vertex Pharmaceuticals
Scientist, Vertex Pharmaceuticals
Operations Research Scientist, Vertex Pharmaceuticals
Chief Technology Officer, Vertex Pharmaceutical
CEO, Virdate Pharmaceuticals
Professor, Western University of Health Sciences
Assistant Director, Worcester Polytechnic Institute
Research Scientist, X-Chem
Senior Director, Lead Discovery, X-Chem
VP of Chemistry, X-Chem

 
  Opal's education and networking conferences, events and summits
 
 
 
 
 
Opal's education and networking conferences, events and summits
  Upcoming Conferences   |   Past Conferences   |   Register   |   Sponsor Info   |   Policies
  Recommend a Speaker   |   Info Request   |   Sponsor Info Request  |  Become a Media Partner
Copyright 2011 Opal Events. All Rights Reserved. FAQ's   |   About Us   |   Privacy Statement   |   Mailing List   |   Contact Us  |   Employment